Doctor profile · Federal record

Dr. Michael Indelicato, D.O.

Rheumatology Physician (CMS: Rheumatology) · Peabody, MA

  • NPI 1154577476
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 18 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
39 Cross St, Suite 103
Peabody, MA 019601670
(978) 532-4077
fax (978) 531-0324

Credentials & registration

NPPES · NUCC
NPI registered
August 2008 — 18 yrs on file
Profile last updated
March 17, 2017
Year of graduation
2008 — 18 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Massachusetts #265526

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1154577476. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
98,878
Distinct HCPCS
10
Medicare allowed
$1,783,367
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 48,000 13 $5
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 20,675 32 $42
J1602 Injection, golimumab, 1 mg, for intravenous use 19,650 24 $13
J1745 Injection, infliximab, excludes biosimilar, 10 mg 5,190 15 $32
J0897 Injection, denosumab, 1 mg 1,980 24 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 690 347 $133
J7050 Infusion, normal saline solution, 250 cc 592 82 $1
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 424 53 $1
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 399 65 $68
36415 Insertion of needle into vein for collection of blood sample 373 221 $8

In context: peer comparison

Among 3 peers in this city , average services per provider: 3,250. This provider delivers 30× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$274
Transactions
13
Manufacturers
3
Payer (manufacturer) Industry Txns Amount
PFIZER INC. 11 $240.53
UCB, Inc. 1 $17.17
ABBVIE INC. 1 $16.03

By nature of payment

Food and Beverage
$274

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,600
Patients
394
Total drug cost
$1,035,793
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 341 87 $16,100
Prednisone Generic 323 71 $2,381
Allopurinol Generic 212 53 $6,092
Methylprednisolone Generic 156 68 $2,336
Meloxicam Generic 76 31 $347
Hydroxychloroquine Sulfate Generic 70 19 $3,419
Xeljanz Xr (Tofacitinib Citrate) Brand 70 0 $385,072
Colchicine Generic 67 25 $5,008
Diclofenac Sodium Generic 62 15 $857
Humira(Cf) Pen (Adalimumab) Brand 48 0 $364,773

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Michael Indelicato's medical specialty?
Dr. Michael Indelicato practices Rheumatology Physician in Peabody, MA.
Where does Dr. Michael Indelicato practice?
Dr. Michael Indelicato practices at 39 Cross St, Peabody, MA 019601670. Office phone: 9785324077.
What is Dr. Michael Indelicato's NPI?
Dr. Michael Indelicato's National Provider Identifier (NPI) is 1154577476, issued by NPPES.
Does Dr. Michael Indelicato accept Medicare assignment?
Yes. Dr. Michael Indelicato accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Indelicato commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.